Medlife starts share buyback program
Romanian private healthcare group Medlife has started on Tuesday a share buyback program that was approved by shareholders in late 2024.
Romanian private healthcare group Medlife has started on Tuesday a share buyback program that was approved by shareholders in late 2024.
The purchase price will be €0.3375 per share, inclusive of dividend, subject to possible adjustments.
The financial results reported at the end of September show total assets of €43.5 million, revenues of €10.6 million, and a net profit of €2.5 million.
The company also seeks the approval of the election of the members of EVERGENT Investments' Board of Directors for a 4-year mandate, as well as the directors' remuneration policy.
The group will offer a maximum of 174,258,721 new shares to investors. The operation starts on June 3, 2024.
Four significant shareholders of One United Properties successfully sold 234,205,285 shares in the Company to local and international institutional investors.
The value of the company increased by 23% in the two years of its presence on the capital market, and at the time of the transfer it had a capitalization of RON 234.7 million.

Arobs Systems, part of the Arobs Group, has signed two digitalization contracts with Romanian government institutions worth a combined €8 million to the company.
Romania's trade balance deficit (FOB/CIF) for January-November 2025 reached €29.77 billion, down €299.6 million (-1.0%) compared to the same period in 2024, according to data published by the National Institute of Statistics (INS).
Retail trade volume in Romania remained flat in November 2025 compared to the previous month, according to the latest data released by Eurostat.
Law firm Kinstellar has assisted renewable energy developer Big Mega Renewable Energy on approximately €100 million project financing with a syndicate of lenders for the construction and operation of the Văcăreni wind farm located in Tulcea County, Romania.
Romania's Competition Council has fined eight companies a total of €32.15 million for participating in an anti-competitive agreement to divide the labour market and limit employee mobility while keeping human resource costs low.